Movement Alert｜Liquidia Technologies Inc Rises 5.57% in Pre-Market Trading, Trading at $90.00

Market Focus07-27

On July 27, Liquidia Technologies Inc rose 5.57% in pre-market trading, trading at $90.00 USD/share, with Turnover of $160,600.

Within the Pharmacy sector where Liquidia Technologies Inc belongs, the overall sector performance is relatively flat. Among individual stocks, Eli Lilly up 0.25%, Johnson & Johnson up 0%, Merck up 0.18%, Bristol-Myers Squibb up 0.34%, Pfizer up 0.16%.

Liquidia Corporation is a biopharmaceutical company that develops, manufactures, and commercializes products for unmet patient needs. Its lead product is YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease. The company is headquartered in Morrisville, North Carolina.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1134201539?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-27 19:02","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1134201539","market":"us","top_or_hot":-1,"title":"Movement Alert｜Liquidia Technologies Inc Rises 5.57% in Pre-Market Trading, Trading at $90.00","media":"Market Focus","content":"<p><p>On July 27, Liquidia Technologies Inc rose 5.57% in pre-market trading, trading at $90.00 USD/share, with Turnover of $160,600.</p><p>Within the Pharmacy sector where Liquidia Technologies Inc belongs, the overall sector performance is relatively flat. Among individual stocks, Eli Lilly up 0.25%, Johnson & Johnson up 0%, Merck up 0.18%, Bristol-Myers Squibb up 0.34%, Pfizer up 0.16%.</p><p>Liquidia Corporation is a biopharmaceutical company that develops, manufactures, and commercializes products for unmet patient needs. Its lead product is YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease. The company is headquartered in Morrisville, North Carolina.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Liquidia Technologies Inc Rises 5.57% in Pre-Market Trading, Trading at $90.00</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Liquidia Technologies Inc Rises 5.57% in Pre-Market Trading, Trading at $90.00\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-07-27 19:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On July 27, Liquidia Technologies Inc rose 5.57% in pre-market trading, trading at $90.00 USD/share, with Turnover of $160,600.</p><p>Within the Pharmacy sector where Liquidia Technologies Inc belongs, the overall sector performance is relatively flat. Among individual stocks, Eli Lilly up 0.25%, Johnson & Johnson up 0%, Merck up 0.18%, Bristol-Myers Squibb up 0.34%, Pfizer up 0.16%.</p><p>Liquidia Corporation is a biopharmaceutical company that develops, manufactures, and commercializes products for unmet patient needs. Its lead product is YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease. The company is headquartered in Morrisville, North Carolina.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LQDA","symbol_name":"Liquidia Technologies Inc","start_time":0,"source_url":"","article_id":"1134201539","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1134201539","pubTimestamp":1785150141,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On July 27, Liquidia Technologies Inc rose 5.57% in pre-market trading, trading at $90.00 USD/share, with Turnover of $160,600.Within the Pharmacy sector where Liquidia Technologies Inc belongs, the...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LQDA":"Liquidia Technologies Inc"},"translate_title":"走势警报|Liquidia Technologies Inc 在盘前交易中上涨 5.57%，交易价格为 90.00 美元","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LQDA":1},"content_text":"On July 27, Liquidia Technologies Inc rose 5.57% in pre-market trading, trading at $90.00 USD/share, with Turnover of $160,600.Within the Pharmacy sector where Liquidia Technologies Inc belongs, the overall sector performance is relatively flat. Among individual stocks, Eli Lilly up 0.25%, Johnson & Johnson up 0%, Merck up 0.18%, Bristol-Myers Squibb up 0.34%, Pfizer up 0.16%.Liquidia Corporation is a biopharmaceutical company that develops, manufactures, and commercializes products for unmet patient needs. Its lead product is YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease. The company is headquartered in Morrisville, North Carolina.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.46.0","shortVersion":"4.46.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1134201539","isCrawlerRequest":true}